Business
Result of General Meeting and Total Voting Rights
Result of General Meeting and Total Voting Rights.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \nRNS Number : 8364X Creo Medical Group PLC 23 December 2019 \n\nCreo Medical Group plc\n(\"Creo\" the \"Company\" or the \"Group\")\n \nResult of General Meeting\nand\nTotal Voting Rights\n \nCreo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that at the General Meeting held earlier today, all resolutions proposed were duly passed unanimously by shareholders. Accordingly, the Company has raised £51.9 million in the Fundraising and has issued and allotted 28,835,173 New Ordinary Shares, conditional only on Admission becoming effective. Admission of the New Ordinary Shares is expected at 8.00 a.m. on 24 December 2019.\n \nFollowing Admission, the Company's issued ordinary share capital will comprise 150,378,758 Ordinary Shares, of which none are held in treasury. The above figure of 150,378,758 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.\n \nA summary of the votes received will be made available on the Group's website at investors.creomedical.com. Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 4 December 2019.\n \nEnquiries:\n \n\n\n\nCreo Medical Group plc\n\n\ninvestors.creomedical.com\n\n\n\n\nRichard Rees (CFO)\n\n\n+44 (0)1291 606 005 \n\n\n\n\n \n\n\n \n\n\n\n\nCenkos Securities\n\n\n+44 (0)20 7397 8900\n\n\n\n\nStephen Keys / Cameron MacRitchie (NOMAD)\n\n\n \n\n\n\n\nMichael Johnson / Russell Kerr (Sales)\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nWalbrook PR Ltd\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Lianne Cawthorne\n\n\nMob: +44 (0)7980 541 893 / +44 (0)7515 909 238\n\n\n\n \nAbout Creo Medical\n \nCreo Medical, founded in 2003, is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and RF energy to surgica...